Table of Contents

1 Market Overview
1.1 Opioids Drug Introduction
1.2 Market Analysis by Type
1.2.1 Oxycodone
1.2.2 Hydromorphone
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 Pain Relief
1.3.2 Anesthesia
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Purdue Pharma
2.1.1 Business Overview
2.1.2 Opioids Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Purdue Pharma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 J&J
2.2.1 Business Overview
2.2.2 Opioids Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 J&J Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva
2.3.1 Business Overview
2.3.2 Opioids Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Teva Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Opioids Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Mylan Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Depomed
2.5.1 Business Overview
2.5.2 Opioids Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Depomed Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 INSYS
2.6.1 Business Overview
2.6.2 Opioids Drug Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 INSYS Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Endo
2.7.1 Business Overview
2.7.2 Opioids Drug Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Endo Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Opioids Drug Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Pfizer Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Hikma
2.9.1 Business Overview
2.9.2 Opioids Drug Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Hikma Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mallinckrodt
2.10.1 Business Overview
2.10.2 Opioids Drug Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Mallinckrodt Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pernix
2.11.1 Business Overview
2.11.2 Opioids Drug Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Pernix Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Egalet
2.12.1 Business Overview
2.12.2 Opioids Drug Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Egalet Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Vistapharm
2.13.1 Business Overview
2.13.2 Opioids Drug Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Vistapharm Opioids Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Opioids Drug Market Competition, by Manufacturer
3.1 Global Opioids Drug Sales and Market Share by Manufacturer
3.2 Global Opioids Drug Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Opioids Drug Manufacturer Market Share
3.3.2 Top 6 Opioids Drug Manufacturer Market Share
3.4 Market Competition Trend
4 Global Opioids Drug Market Analysis by Regions
4.1 Global Opioids Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Opioids Drug Sales by Regions (2012-2017)
4.1.2 Global Opioids Drug Revenue by Regions (2012-2017)
4.2 North America Opioids Drug Sales and Growth (2012-2017)
4.3 Europe Opioids Drug Sales and Growth (2012-2017)
4.4 Asia-Pacific Opioids Drug Sales and Growth (2012-2017)
4.5 South America Opioids Drug Sales and Growth (2012-2017)
4.6 Middle East and Africa Opioids Drug Sales and Growth (2012-2017)
5 North America Opioids Drug by Countries
5.1 North America Opioids Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Opioids Drug Sales by Countries (2012-2017)
5.1.2 North America Opioids Drug Revenue by Countries (2012-2017)
5.2 USA Opioids Drug Sales and Growth (2012-2017)
5.3 Canada Opioids Drug Sales and Growth (2012-2017)
5.4 Mexico Opioids Drug Sales and Growth (2012-2017)
6 Europe Opioids Drug by Countries
6.1 Europe Opioids Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Opioids Drug Sales by Countries (2012-2017)
6.1.2 Europe Opioids Drug Revenue by Countries (2012-2017)
6.2 Germany Opioids Drug Sales and Growth (2012-2017)
6.3 UK Opioids Drug Sales and Growth (2012-2017)
6.4 France Opioids Drug Sales and Growth (2012-2017)
6.5 Russia Opioids Drug Sales and Growth (2012-2017)
6.6 Italy Opioids Drug Sales and Growth (2012-2017)
7 Asia-Pacific Opioids Drug by Countries
7.1 Asia-Pacific Opioids Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Opioids Drug Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Opioids Drug Revenue by Countries (2012-2017)
7.2 China Opioids Drug Sales and Growth (2012-2017)
7.3 Japan Opioids Drug Sales and Growth (2012-2017)
7.4 Korea Opioids Drug Sales and Growth (2012-2017)
7.5 India Opioids Drug Sales and Growth (2012-2017)
7.6 Southeast Asia Opioids Drug Sales and Growth (2012-2017)
8 South America Opioids Drug by Countries
8.1 South America Opioids Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Opioids Drug Sales by Countries (2012-2017)
8.1.2 South America Opioids Drug Revenue by Countries (2012-2017)
8.2 Brazil Opioids Drug Sales and Growth (2012-2017)
8.3 Argentina Opioids Drug Sales and Growth (2012-2017)
8.4 Columbia Opioids Drug Sales and Growth (2012-2017)
9 Middle East and Africa Opioids Drug by Countries
9.1 Middle East and Africa Opioids Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Opioids Drug Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Opioids Drug Revenue by Countries (2012-2017)
9.2 Saudi Arabia Opioids Drug Sales and Growth (2012-2017)
9.3 UAE Opioids Drug Sales and Growth (2012-2017)
9.4 Egypt Opioids Drug Sales and Growth (2012-2017)
9.5 Nigeria Opioids Drug Sales and Growth (2012-2017)
9.6 South Africa Opioids Drug Sales and Growth (2012-2017)
10 Global Opioids Drug Market Segment by Type
10.1 Global Opioids Drug Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Opioids Drug Sales and Market Share by Type (2012-2017)
10.1.2 Global Opioids Drug Revenue and Market Share by Type (2012-2017)
10.2 Oxycodone Sales Growth and Price
10.2.1 Global Oxycodone Sales Growth (2012-2017)
10.2.2 Global Oxycodone Price (2012-2017)
10.3 Hydromorphone Sales Growth and Price
10.3.1 Global Hydromorphone Sales Growth (2012-2017)
10.3.2 Global Hydromorphone Price (2012-2017)
10.4 Codeine Sales Growth and Price
10.4.1 Global Codeine Sales Growth (2012-2017)
10.4.2 Global Codeine Price (2012-2017)
10.5 Fentanyl Sales Growth and Price
10.5.1 Global Fentanyl Sales Growth (2012-2017)
10.5.2 Global Fentanyl Price (2012-2017)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2012-2017)
10.6.2 Global Other Price (2012-2017)
11 Global Opioids Drug Market Segment by Application
11.1 Global Opioids Drug Sales Market Share by Application (2012-2017)
11.2 Pain Relief Sales Growth (2012-2017)
11.3 Anesthesia Sales Growth (2012-2017)
11.4 Other Sales Growth (2012-2017)
12 Opioids Drug Market Forecast (2017-2022)
12.1 Global Opioids Drug Sales, Revenue and Growth Rate (2017-2022)
12.2 Opioids Drug Market Forecast by Regions (2017-2022)
12.2.1 North America Opioids Drug Market Forecast (2017-2022)
12.2.2 Europe Opioids Drug Market Forecast (2017-2022)
12.2.3 Asia-Pacific Opioids Drug Market Forecast (2017-2022)
12.2.4 South America Opioids Drug Market Forecast (2017-2022)
12.2.5 Middle East and Africa Opioids Drug Market Forecast (2017-2022)
12.3 Opioids Drug Market Forecast by Type (2017-2022)
12.4 Opioids Drug Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source